Decreasing mortality from non‐Hodgkin lymphoma in Australia
Authors:
- 29 December 2008
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 38 (12) , 921-924
Abstract
Based on the number of new cases (incidence), non‐Hodgkin lymphoma is an increasingly common cancer in Australia and many developed countries. Until recently, mortality trends have been stable or slightly increasing. However, since the year 2000, mortality has decreased every year by an average of 5.1% per year (95% confidence interval (CI) −7.1 to −3.1%), whereas incidence has continued to increase at 0.9% per year (95%CI 0.6 to 1.2%). It was not possible with the population‐based registry data available to us to untangle the causes of the decrease in mortality. The stable mortality rates during the 1990s (in the face of increasing incidence) might have been because of introduction of novel therapies such as autologous stem cell transplant for relapsed diffuse large cell lymphoma or the purine analogue‐based therapy for indolent lymphomas. A plausible explanation for the large decrease in mortality since 2000 is the introduction of the monoclonal antibody rituximab.Keywords
This publication has 13 references indexed in Scilit:
- Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska NativesCancer, 2007
- The non-Hodgkin lymphomas: A review of the epidemiologic literatureInternational Journal of Cancer, 2007
- Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in EuropeEuropean Journal of Cancer, 2007
- Epidemiology and etiology of non-Hodgkin lymphoma – a reviewActa Oncologica, 2006
- Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British ColumbiaJournal of Clinical Oncology, 2005
- Follicular Lymphoma International Prognostic IndexBlood, 2004
- Expert Review of Non-Hodgkin’s Lymphomas in a Population-Based Cancer RegistryCancer Epidemiology, Biomarkers & Prevention, 2004
- Increasing incidence of non‐Hodgkin's lymphoma in Canada, 1970–1996: age–period–cohort analysisHematological Oncology, 2003
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993